Home ›
Trademark Categories ›
Pharmaceuticals ›
2018 ›
RA ›
RANIMAB
Trademark search for:
RANIMAB
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2018-10-05 — Application filed
2018-11-01 — Sn assigned for sect 66a appl from ib
2018-11-07 — Application filed
2018-11-13 — Application filed
2019-01-16 — Assigned to examiner
2019-01-23 — Final disposition recorded
2019-01-24 — Office action issued
2019-02-06 — Office action issued
2019-02-06 — Office action issued
2019-02-22 — Office action issued
2019-06-12 — Attorney/dom.rep.revoked and/or appointed
2019-06-12 — Teas revoke/app/change addr of atty/dom rep received
2019-06-14 — Teas/email correspondence entered
2019-06-14 — Office action issued
2019-06-14 — Correspondence received in law office
2019-06-17 — Approved for pub - principal register
2019-06-25 — Withdrawn from pub - comm.office request
2019-07-03 — Examiners amendment -written
2019-07-03 — Approved for pub - principal register
2019-07-03 — Examiners amendment e-mailed
2019-07-03 — Notification of examiners amendment e-mailed
2019-07-03 — Examiner's amendment entered
2019-07-03 — Previous allowance count withdrawn
2019-07-15 — Assigned to lie
2019-07-31 — Notification of possible opposition sent to ib
2019-07-31 — Notification of notice of publication e-mailed
2019-07-31 — Notice of start of opposition period created, to be sent to ib
2019-08-15 — Change of owner received from ib
2019-08-16 — Notification processed by ib
2019-08-20 — Published for opposition
2019-08-20 — Official gazette publication confirmation e-mailed
2019-09-17 — Extension of time to oppose received
2019-10-08 — Teas post publication amendment received
2019-11-05 — Assigned to petition staff
2019-11-06 — Review of correspondence complete
2019-12-02 — Final status recorded
2019-12-10 — Correspondence received in law office
2019-12-20 — Death of international registration
2019-12-21 — Notification of effect of cancellation of intl reg e-mailed
2020-01-08 — Review of correspondence complete - address updated
Owner Information
Klinge Biopharma GmbH
DE
Klinge Biopharma GmbH
DE
Klinge Pharma GmbH
Holzkirchen DE
Correspondent
Charles T. J. Weigell FROSS ZELNICK LEHRMAN & ZISSU, P.C. 151 WEST 42nd St., 17 Fl. NEW YORK, NY 10036 UNITED STATES
Filing Details
Filing Date:
2018-10-05
Status Date:
2019-12-02
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.